FDA warns about cybersecurity re: hacking risk for hospital infusion pump

From the FDA’s Safety Communication updates (click to subscribe)

“Today [31 July 2015] the FDA issued a Safety Communication on cybersecurity vulnerabilities of the Hospira Symbiq Infusion System.

Hospira and an independent researcher confirmed that it is possible to access the Symbiq Infusion System remotely through a hospital’s network. This could allow unauthorized users to control the infusion pump and change the dosage it delivers, potentially leading to over- or under-infusion of critical patient therapies.

The FDA and Hospira are not aware of any patient adverse events or unauthorized access of a Symbiq Infusion System in a health care setting. Health care facilities can reduce the risk of unauthorized access by transitioning to an alternative infusion pump and implementing recommendations from the FDA Safety Communication.”

“The Food and Drug Administration said Friday it’s the first time it has warned caregivers to stop using a product because of a cybersecurity risk.” Modern Healthcare article

Further reading

This entry was posted in campaigns and awareness, health / medical, medical devices, patient safety and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s